ArticleEMBO molecular medicine2024

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Sarah Proteau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.